Beschreibung
Pathway analysis of differentially abundant gut microbiota in berberine-treated versus untreated cats with ulcerative colitis reveals enrichment in metabolic pathways linked to anti-inflammatory responses. The data support berberine's role in modulating gut microbiota-mediated immune regulation.
Figure 12
DiagramSource Paper
Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.Cite This Figure
![Figure 12: Pathway analysis of differentially abundant gut microbiota in berberine-treated versus untreated cats with ulcerative colitis reveals enrichment in metabolic pathways linked to anti-inflammatory responses. The data support berberine's role in modulating gut microbiota-mediated immune regulation.]() > Source: Xueying Li et al. "Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerat." *Microbiology spectrum*, 2022. PMID: [36287004](https://pubmed.ncbi.nlm.nih.gov/36287004/)
<figure> <img src="" alt="Pathway analysis of differentially abundant gut microbiota in berberine-treated versus untreated cats with ulcerative colitis reveals enrichment in metabolic pathways linked to anti-inflammatory responses. The data support berberine's role in modulating gut microbiota-mediated immune regulation." /> <figcaption>Figure 12. Pathway analysis of differentially abundant gut microbiota in berberine-treated versus untreated cats with ulcerative colitis reveals enrichment in metabolic pathways linked to anti-inflammatory responses. The data support berberine's role in modulating gut microbiota-mediated immune regulation.<br> Source: Xueying Li et al. "Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerat." <em>Microbiology spectrum</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36287004/">36287004</a></figcaption> </figure>